New Trial Shows Effectiveness of BPaL Regimen for Highly Drug-Resistant TB

TB Alliance’s ZeNix trial in South Africa and Eastern Europe sought to optimize the 6-month treatment regimen with reduced exposure to the drug linezolid. Read Here.

4 views0 comments

Recent Posts

See All

WHO 2021 Genetic Susceptibility Testing Statement

This document summarizes the WHO’s review of various diagnostics for TB. Most of it is not new, but important additions are evaluation of molecular methods for detection of resistance to INH (pages 50

WHO GLOBAL TB PROGRAMME NEWSFLASH

Active TB Drug Safety Monitoring and Management (aDSM) global database: Outcome of the assessment and future of data reporting. Read here.